CAMP4 Therapeutics is pioneering a new approach to upregulate genes by targeting regulatory RNA using programmable oligonucleotide therapeutics.

Biotechnology

Therapeutics

CAMP4 Therapeutics

Josh Mandel-Brehm

Regulatory Affairs Leader

In Vivo Scientist

Yuchun Guo

Brian E. Schwartz

Caleb Moore

Kelly Gold

Satya Kuchimanchi

Head of Intellectual Property

Office Administrator

Michelle Gates

David Bumcrot

The Research and Development team at CAMP4 Therapeutics is responsible for pioneering innovative approaches to gene upregulation by targeting regulatory RNA with programmable oligonucleotide therapeutics. Comprised of experts in data science, molecular biology, biochemistry, and computational biology, the team works collaboratively on the discovery, design, and translational research of new therapeutic compounds, aiming to harness the power of RNA regulation to treat genetic disorders.

Research and Development

Director Team

Scientific Advisors

Research and Development

About

Team members